Hemostasis Today

September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
Aug 14, 2026, 23:15

Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels

Markus Müller, President (Rector) at University of Vienna, Member of the Board of Trustees at Austrian National Library, President of the Supreme Medical Council at Federal Ministry of Labour, Social Affairs, Health, Care and Consumer Protection, Chairman of the Supervisory Board at University Hospital AKH Vienna, shared a post on LinkedIn about a recent article by Scott B. Vafai et al., published in NEJM, adding:

“Fascinating article about a new base editing approach targeting PCSK9 to lower cholesterol levels in the NEJM.”

Title: In Vivo Base Editing of PCSK9 with VERVE-102 for Hypercholesterolemia

Authors: Scott B. Vafai, Jörg Täubel, Thomas Ashdown, Riyaz S. Patel, Sadaf Diamondali, Jaimini Cegla, Handrean Soran, Bilal Bashir, Alexander Abitbol, Daniel Gaudet, Alex Lauzière, Liam R. Brunham, David E. Newby, Stephen J. Nicholls, Russell S. Scott, Jane Kerr, Jean-Claude Tardif, Catherine Lunken, Steve E. Humphries, Verena Karsten, Patrick D. Tyler, Xinyan Zhang, Nidal Huniti, Patrick A. Flight, Chelsey L. Jensen, Rick Falzone, Joseph C. Biedenkapp, Troy Lister, Leslie E. Stolz, Amit V. Khera, Sekar Kathiresan

Markus Müller

Stay updated on all scientific advances with Hemostasis Today.